Biogen to Present Clinical Data from Neurology Portfolio at AAN Annual Meeting
April 14, 2014 at 07:31 AM EDT
- Two-Year Data from Pivotal Phase 3 ADVANCE Study for PLEGRIDY™ (Peginterferon Beta-1a) to Be Presented - - New TECFIDERA® ...